Table 1.

Biochemical outcomes between small and large PA lesion groups with different cut-offs for the maximum lesion size in pathology

	Test cohort (n =114)						Test cohort with adrenal venous sampling data (n = 90)
Group (cut-off for the maximum lesion size)	Complete success	Partial and absent success	p	Complete and partial success	Absent success	p	Complete success	Partial and absent success	p	Complete and partial success	Absent success	p
L-PAL (>6 mm)	66 (79.5%)	17 (20.5%)	0.06	80 (96.4%)	3 (3.6%)	0.004	52 (77.6%)	15 (22.4%)	0.06	64 (95.5%)	3 (4.5%)	0.02
S-PAL (<6 mm)	19 (61.3%)	12 (38.7%)		24 (77.4%)	7 (22.6%)		13 (56.5%)	10 (43.5%)		18 (78.3%)	5 (21.7%)
L-PAL (>5 mm)	70 (80.5%)	17 (19.5%)	0.02	84 (96.6%)	3 (3.4%)	0.002	55 (78.6%)	15 (21.4%)	0.02	67 (95.7%)	3 (4.3%)	0.01
S-PAL (<5 mm)	15 (55.6%)	12 (44.4%)		20 (74.1%)	7 (25.9%)		10 (50.0%)	10 (50.0%)		15 (75.0%)	5 (25.0%)
L-PAL (>4 mm)	70 (78.7%)	19 (21.3%)	0.07	86 (96.6%)	3 (3.4%)	<0.001	55 (76.4%)	17 (23.6%)	0.087	67 (95.7%)	3 (4.3%)	0.01
S-PAL (<4 mm)	15 (60.0%)	10 (40.0%)		18 (72.0%)	7 (28.0%)		10 (55.6%)	8 (44.4%)		15 (75.0%)	5 (25.0%)
L-PAL (>3 mm)	71 (78.0%)	20 (22.0%)	0.11	87 (95.6%)	4 (4.4%)	0.004	56 (76.7%)	17 (23.3%)	0.07	70 (95.9%)	3 (4.1%)	0.005
S-PAL (<3 mm)	14 (60.9%)	9 (39.1%)		17 (73.9%)	6 (26.1%)		9 (52.9%)	8 (47.1%)		12 (70.6%)	5 (29.4%)
L-PAL (>2 mm)	73 (76.8%)	22 (23.2%)	0.25	90 (94.7%)	5 (5.3%)	0.01	58 (75.3%)	19 (24.7%)	0.177	73 (94.8%)	4 (5.2%)	0.01
S-PAL (<2 mm)	12 (63.2%)	7 (36.8%)		14 (73.7%)	5 (26.3%)		7 (53.8%)	6 (46.2%)		9 (69.2%)	4 (30.8%)

S-PAL and L-PAL represent the small and large PA lesion groups, respectively. Numbers (percentages) indicate the number of cases (percentage of the number of cases). p values were calculated by Fisher’s exact tests. Bold and italicized characters indicate data with p values < 0.05 and ≥0.05, respectively